Difference between revisions of "Drug-drug, drug-allergy interaction checks (MU2)"
From OpenEMR Project Wiki
Bradymiller (talk | contribs) |
Bradymiller (talk | contribs) (→Links) |
||
Line 22: | Line 22: | ||
==Links== | ==Links== | ||
:*[[OpenEMR Certification Stage II Meaningful Use|OpenEMR Certification Stage II Meaningful Use Main Project Page]] | |||
[[Category:Certification]][[Category:Certification Stage II]] | [[Category:Certification]][[Category:Certification Stage II]] |
Revision as of 20:28, 9 September 2012
Overview
MU Requirements
Per ONC
- Taken from ONC Final Rule
(2) Drug-drug, drug-allergy interaction checks. (i) Interventions. Before a medication order is completed and acted upon during computerized provider order entry (CPOE), interventions must automatically and electronically indicate to a user drug-drug and drug-allergy contraindications based on a patient’s medication list and medication allergy list. (ii) Adjustments. (A) Enable the severity level of interventions provided for drug-drug interaction checks to be adjusted. (B) Limit the ability to adjust severity levels to an identified set of users or available as a system administrative function.